Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

33.31
+0.15000.45%
Volume:961.71K
Turnover:32.09M
Market Cap:20.49B
PE:26.33
High:33.67
Open:33.33
Low:33.15
Close:33.16
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.70
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.44
PE(LYR):21.67

Loading ...

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 30

Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline

TIPRANKS
·
Apr 28

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 28

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Apr 25

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Apr 23

Goldman Sachs Upgrades Genmab to Buy From Neutral, Adjusts Price Target to $30.50 From $24.50

MT Newswires Live
·
Apr 22

Genmab upgraded to Outperform from Neutral at BNP Paribas

TIPRANKS
·
Apr 22

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Apr 21

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Apr 18

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Apr 16

Genmab Reports Q1 Net Sales of DARZALEX

MT Newswires Live
·
Apr 14

Genmab reports Darzalex Q1 worldwide sales $3.964B

TIPRANKS
·
Apr 14

Genmab A/S Stock Rises Monday

Dow Jones
·
Apr 14

Genmab Says Rinatabart Sesutecan Combination Tolerable in Patients With Advanced Ovarian Cancer

MT Newswires Live
·
Apr 13

Genmab presents safety, tolerability data on Rina-S with bevacizumab

TIPRANKS
·
Apr 13

Genmab A/S Stock Rises Thursday, Outperforms Market

Dow Jones
·
Apr 10

Genmab A/S Stock Falls Tuesday, Outperforms Market

Dow Jones
·
Apr 08

Wells Fargo Sticks to Its Buy Rating for Genmab (GMAB)

TIPRANKS
·
Apr 02

Genmab A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
Apr 02

Genmab A/S Stock Rises Monday, Underperforms Market

Dow Jones
·
Mar 31